August J. Moretti
2022 - 4D Molecular Therapeutics
In 2022, August J. Moretti earned a total compensation of $2.2M as Chief Financial Officer at 4D Molecular Therapeutics, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $192,696 |
|---|---|
| Option Awards | $1,508,100 |
| Salary | $459,644 |
| Other | $13,500 |
| Total | $2,173,940 |
Moretti received $1.5M in option awards, accounting for 69% of the total pay in 2022.
Moretti also received $192.7K in non-equity incentive plan, $459.6K in salary and $13.5K in other compensation.
Rankings
In 2022, August J. Moretti's compensation ranked 1,647th out of 5,758 executives tracked by ExecPay. In other words, Moretti earned more than 71.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,647 out of 5,758 | 71st |
Division Manufacturing | 851 out of 3,135 | 73rd |
Major group Chemicals And Allied Products | 337 out of 1,421 | 76th |
Industry group Drugs | 311 out of 1,322 | 77th |
Industry Biological Products, Except Diagnostic Substances | 76 out of 291 | 74th |
Source: SEC filing on April 12, 2023.
Moretti's colleagues
We found two more compensation records of executives who worked with August J. Moretti at 4D Molecular Therapeutics in 2022.